Reusable receptacles are more environmentally friendly than disposable ones, but without proper hygiene they can accumulate ...

Promising clinical results observed in the first 88 patients evaluated so far, confirming the safety and an important clinical benefit for patients Control of the infection at 3 months for ...

APSA-02 is under clinical development by Armata Pharmaceuticals and currently in Phase II for Bacteremia. According to GlobalData, Phase II drugs for Bacteremia have a 66% phase transition success ...

Pune: Doctors have reported a steady increase in infections resistant to antibiotics among children in the city, indicating that humans without the us.